Company intelligence / Profile preview
Eirion Therapeutics
Woburn, Massachusetts, United Stateseirionthera.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Eirion Therapeutics develops next-generation prescription products for aesthetic medicine and medical dermatology. Its clinical-stage pipeline includes treatments targeting wrinkles, excessive sweating, androgenic alopecia, and hair greying. The company has reported promising early results with novel topical agents for androgenic alopecia as of January 2025. Lead assets include a botulinum toxin A product in Phase 2 trials for hyperhidrosis and small molecule/topical drugs in earlier stages.
- Therapeutic areas
- Dermatology
- Modalities
- Toxin (e.g., Botulinum toxin A)Small molecule drugUniversal CAR-T (listed in pipeline data but not detailed elsewhere)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Haohai Biological Technology (investor/partner)
Beyond the preview
Go deeper on Eirion Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eirion Therapeutics.